Sign in
4

Changes in Ownership

Acurx Pharmaceuticals, Inc. Filed Acc 0001104659-26-046835

Options or other derivatives

  • President and CEO acquired 37,100 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
LUCI DAVID P President and CEO 2026-04-20 Grant or award · Stock Option +37,100 37,100 D
Loading xslF345X06/tm2612397-2_4seq1.xml…